nucala
glaxosmithkline trading services - mepolizumabs - astma - zāles obstruktīvu elpceļu slimību, - severe eosinophilic asthmanucala is indicated as an add-on treatment for severe refractory eosinophilic asthma in adults, adolescents and children aged 6 years and older. chronic rhinosinusitis with nasal polyps (crswnp)nucala is indicated as an add-on therapy with intranasal corticosteroids for the treatment of adult patients with severe crswnp for whom therapy with systemic corticosteroids and/or surgery do not provide adequate control. eosinophilic granulomatosis with polyangiitis (egpa)nucala is indicated as an add-on treatment for patients aged 6 years and older with relapsing-remitting or refractory eosinophilic granulomatosis with polyangiitis (egpa). hypereosinophilic syndrome (hes)nucala is indicated as an add-on treatment for adult patients with inadequately controlled hypereosinophilic syndrome without an identifiable non-haematologic secondary cause.
calafos 750 mg košļājamās tabletes
viatris limited, ireland - lantāns - košļājamā tablete - 750 mg
caladeks (paziņots 2009.) tablete
robinson pharma inc. - tablete
lamberts® calasorb® augstas devas kalcijs 800 mg ar d3 vitamīnu (2021.) tablete
lamberts healthcare ltd. - tablete
bronchos ziemas balzams (paziņots 2009.) cits, balzāms
acorus calamus, uab - cits, balzāms
smiltsĒrkšĶu eĻĻa (paziņots 2009.) cits, eļļa
uab ″acorus calamus″ - cits, eļļa
roŽu augĻu sĪrups +c vitamīns (paziņots 2009.) sīrups
uab ″acorus calamus″ - sīrups
bronchos pastilas ar medu (paziņots 2013.) pastila
ražots Šveicē pēc uab „acorus calamus” pasūtījuma - pastila
bronchos pastilas ar salviju (paziņots 2013.) pastila
ražots Šveicē pēc uab „acorus calamus” pasūtījuma - pastila
nervus mgb6 (paziņots 2010.) kapsula
acorus calamus, uab - kapsula